Abstract:Background: Placenta previa is a common cause of postpartum hemorrhage (PPH) that contributes substantively to maternal morbidity and mortality rates. Tranexamic acid is an antifibrinolytic drug that is useful for the treatment of PPH. The recommendation from many guidelines is to start giving tranexamic acid as soon as PPH is diagnosed to reduce postpartum blood loss. Furthermore, some studies report the beneficial use of tranexamic acid given as a prophylactic before Cesarean section to decrease intraoperative blood loss and prevent PPH. To the authors’ knowledge, in high-risk obstetrics case such as placenta previa, there was insufficient data to support recommendations of the use of tranexamic acid for prevent PPH. Objective: To evaluate the efficacy of supplementary intravenous tranexamic acid before cesarean section versus prophylactic intravenous oxytocin after placenta delivery alone to decrease intraoperative blood loss and prevent PPH in placenta previa. Material and Methods: The present study conducted a double blinded placebo control trial comparing adjunct 1 g tranexamic acid given intravenously before skin incision with prophylactic intravenous oxytocin after placenta delivery alone before cesarean section for placenta previa. The study recruited 60 women who were diagnosed with placenta previa at gestational age (GA) of more than 28 completed weeks undergoing emergency cesarean section due to active bleeding or scheduled for elective cesarean section at 37 completed weeks at Chonburi Hospital between July 2021 and July 2022. The primary outcome was intraoperative blood loss. Results: Sixty diagnosed placenta previa women were recruited, with 30 patients per group. Group I patients were given 1 g tranexamic acid and Group II were given a placebo of 100 ml NSS before skin incision. Both groups received intravenous oxytocin 20 units after placenta delivery. The main outcome showed that preoperative tranexamic acid intravenous reduced intraoperative blood loss significantly compared with the placebo at 349.5 ml (range of 168 to 2,200) versus 619 ml (range of 288 to 3,243), p<0.001. The secondary outcome showed a significant decrease in the incidence of PPH at 4 (13.33%) versus 10 (33.33%), p=0.030 and decreased in the incidence of blood transfusion of more than one unit from 5 (16.67%) versus 13 (43.33%), p=0.047. Conclusion: Prophylactic supplementary 1 g tranexamic acid intravenously before cesarean section to prophylactic intravenous oxytocin after placental delivery was found to effectively reduce intraoperative blood loss and PPH. Keywords: Tranexamic acid; Preoperative; Placenta previa; Intraoperative blood loss; Cesarean section

Carboprost Tromethamine with Oxytocin in Placenta Previa and Hemorrhage: an Analysis on the Effect of Efficacy, Safety and Blood Loss

Effects of Prophylactic Uterine Artery Embolization on Second-Trimester Induced Abortions in Patients with Placenta Previa

Effect of Preoperative Prophylactic Intravenous Tranexamic Acid on Perioperative Blood Loss Control in Patients Undergoing Cesarean Delivery: a Systematic Review and Meta-Analysis

The Incidence of Postpartum Hemorrhage in Pregnant Women with Placenta Previa: A Systematic Review and Meta-Analysis

Cohort Study Summary of the Effects of Carboprost Tromethamine Combined with Oxytocin on Infant Outcome, Postpartum Hemorrhage and Uterine Involution of Parturients Undergoing Cesarean Section

Using a Cervical Ripening Balloon to Penetrate the Placenta and Quickly Reduce Bleeding by Pressing Against the Placenta During Pregnancy Termination for Patients with Placenta Previa in the Second Trimester

Evaluation of Application Time and Effects of Carboprost Trometamol for Patient with Complete Placenta Praevia in Cesarean-Section

Transverse Parallel Compression Suture: a New Suturing Method for Successful Treating Pernicious Placenta Previa During Cesarean Section

Application of Carboprost Tromethamine in preventing postpartum hemorrhage of patient with pregnancy complicated with hysteromyoma

Effect of Prophylactic Balloon Occlusion of Internal Iliac Artery in Pregnancies Complicated by Placenta Previa and Accreta.

Efficacy of Preoperative Intravenous Tranexamic Acid Before Cesarean Section in Placenta Previa: A Randomized Double Blind Control Trial

Clamp sustained compression of lower uterine segment for treatment of postpartum hemorrhage of placenta previa

Effect of combined administration of carboprost tromethamine and ergometrine on uterine atony-induced postpartum hemorrhage

Clinical observation of oxytocin combined with prostaglandins in prevention of postpartum hemorrhage of high-risk pregnancy puerperae with caesarean section

The Method for Termination of Mid-Trimester Pregnancy with Placenta Previa: A Case Study

Effects of Carboprost Tromethamine Combined with Modified B-Lynch Sutura on Prognosis and Life Quality in Treatment of Patients with Refractory Uterine Inertia Postpartum Hemorrhage

TRAPP-TRanexamic Acid for the Prevention of Postpartum Hemorrhage in Pregnant Women with Placenta Previa: a Multicenter Randomized, Double-Blind, Placebo-Controlled Trial

A New Surgical Technique “cervical Internal Os Plasty” in Cesarean Delivery for Placenta Previa Accreta

Efficacy analysis of balloon hemostasis technologies in parturient with placenta previa: A hemodynamic numerical and clinical retrospective study

Different Methods for Termination of Mid-trimester Pregnancy With Placenta Previa

Parallel Loop Binding Compression Suture, a Modified Procedure for Pernicious Placenta Previa Complicated with Placenta Increta